All the news Showing 3 of 3 articles from: Treatment for hepatocellular carcinomaGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Antihistamine use halved the risk of liver cancer in people with viral hepatitis Keith Alcorn / 08 February 2022 Antihistamines used for relief of allergies and hay fever halved the risk of developing hepatocellular carcinoma (HCC; liver cancer) in people with viral hepatitis during a ten-year follow-up period, a review of ... Immunotherapy plus arterial infusion chemotherapy shows promise for advanced liver cancer Liz Highleyman / 12 July 2021 An experimental immune checkpoint inhibitor plus chemotherapy delivered directly into the hepatic artery in the liver led to good outcomes in people with locally advanced hepatocellular carcinoma (HCC), the most common type of ... Immunotherapy combinations show promise for advanced liver cancer Liz Highleyman / 02 September 2020 Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer, according to a set of late-breaking presentations last week at the 2020 Digital ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive